Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 92 3-Year ROIIC % is 340.81 as of Dec. 2025, which is 7611% above its 10-year median of 4.42. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $10.32. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, M1 Kliniken AG ranks better than 98.21% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
M1 Kliniken AG's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 340.81%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for M1 Kliniken AG's 3-Year ROIIC % or its related term are showing as below:
MKLNF's 3-Year ROIIC % is ranked better than 98.21% of 112
companies
in the Medical Distribution industry
Industry Median: 2.295
vs MKLNF: 340.81
M1 Kliniken AG (OTCPK:MKLNF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
M1 Kliniken AG 3-Year ROIIC % Related Terms
M1 Kliniken AG 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, M1 Kliniken AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
M1 Kliniken AG (MKLNF) has a 3-Year ROIIC % of 340.81 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on M1 Kliniken AG and its competitors. This is 7611% above median its historical median of 4.42. According to the industry distribution chart, M1 Kliniken AG ranks #2 out of 112 companies in the Medical Distribution industry, placing it in the top 1.8%.
Is M1 Kliniken AG's 3-Year ROIIC % too high?
M1 Kliniken AG's current 3-Year ROIIC % of 340.81 is 7611% above median its 10-year median of 4.42. The Medical Distribution industry median 3-Year ROIIC % is 2.30. M1 Kliniken AG's value of 340.81 is 14750.1% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #2 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's 3-Year ROIIC % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #2 out of 112 companies for 3-Year ROIIC %. This places M1 Kliniken AG in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 2.30. M1 Kliniken AG's value of 340.81 is 14750.1% above this benchmark. While the company's 10-year median is 4.42 vs. the industry median of 2.30, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.30, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current 3-Year ROIIC % of 340.81 is 14750.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current 3-Year ROIIC % is 340.81, which is 7611% above median its own 10-year median of 4.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current 3-Year ROIIC % of 340.81. The stock's GF Value™ is $10.32, compared to a current price of $11.73 — trading 13.6% above its estimated fair value. The current 3-Year ROIIC % is 340.81, which is 7611% above median its 10-year median of 4.42 and 14750.1% above the Medical Distribution industry median of 2.30. M1 Kliniken AG's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current 3-Year ROIIC % is 340.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 13.6% above its estimated GF Value™ of $10.32.
Key valuation signals for MKLNF:
3-Year ROIIC %: 340.81 (7611% above median its 10-year median of 4.42)
GF Value™: $10.32 vs. price of $11.73 (13.6% above fair value)
Industry Position: 14750.1% above the Medical Distribution median (#2 of 112)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
